Facebook Icon Skip to main content

COVID-19 Treatments

COVID‑19 Treatments

While we currently have highly effective vaccines that protect against the virus that causes COVID-19, medical research continues to identify effective treatments.

Treatments approved and authorized for emergency use by the Food and Drug Administration (FDA) are listed below.

Talk to your healthcare provider about which treatment might be right for you.


Available COVID-19 Treatments

There are several treatments being used for COVID-19. They are for different kinds of people facing different risks, and they are in extremely short supply around the county. Please do NOT go to the emergency room to seek these treatments. Learn more here.

  • Remdesivir (Veklury) is an FDA approved treatment intended for qualifying adults and pediatric patients who are sick enough to need hospitalization.
  • Monoclonal antibodies and antivirals are for adults and children that are at risk for severe disease.
  • Treatments designed to support ventilation and supplemental oxygen procedures are also available.

Visit Know Your Treatment Options For COVID-19 for additional information regarding treatment options. Please contact your healthcare provider to determine which treatment might be right for you.

Emergency Use Authorization (EUA) Treatments

Monoclonal antibodies (mAbs)

Monoclonal antibodies (mAbs) treatments are issued by the FDA for emergency use under certain conditions. Currently, mAbs are used for treatment of people who have COVID-19 and:

  • To block the virus from entering your cells.
  • To reduce the severity of disease and incidence of hospitalization.
  • Preventive treatment for high-risk people who may be routinely exposed to the virus that causes COVID-19.
  • Preventive treatment for people who are immunocompromised or cannot receive the COVID-19 vaccine for medical reasons.
4 things to know about Evusheld (flyer)

Antiviral treatments

Different antiviral treatments work in different ways.

Molnupiravir is an oral antiviral that targets the viral RNA's reproduction of the SARS-CoV-2.

Paxlovid disrupts the replication of SARS-CoV-2 in the body by binding to the 3CL-like protease, an enzyme crucial to the virus’ function and reproduction.


 Accessibility: For individuals with disabilities or individuals who speak a language other than English, OHA can provide information in alternate formats such as translations, large print, or braille. Contact the Health Information Center at 1-971-673-2411, 711 TTY or COVID19.LanguageAccess@dhsoha.state.or.us

Printing requests: You can download materials on this page. OHA does not offer paper versions. Please feel free to print whatever you need.

Language access: OHA is working to provide original content in languages other than English. Many of the materials in our community resources section are available in multiple languages. OHA is also providing the Google™ Translate option to assist you in reading the OHA website in languages other than English. Google™ Translate cannot translate all types of documents and may not provide an exact translation. Anyone relying on information obtained from Google™ Translate does so at their own risk. OHA does not make any promises, assurances, or guarantees as to the accuracy of the translations provided.

General vaccine questions: ORCOVID@211info.org


Facebook Español Twitter YouTube